Advertisement
Advertisement

EVOK

EVOK logo

Evoke Pharma Inc

4.56
USD
-0.03
-0.65%
Dec 18, 15:59 UTC -5
Closed
...

Evoke Pharma Inc Profile

About

Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Company's lead product candidate, EVK-001, is in late stage clinical testing which is intended for the treatment of diabetic gastroparesis. Evoke Pharma, Inc. is based in San Diego, California.

Info & Links

CEO

David A. Gonyer

Headquarters

420 STEVENS AVENUE, SUITE 230
SOLANA BEACH, CA 92075, UNITED STATES

Industry

Pharmaceuticals Major

Sector

Health Technology

Website

https://evokepharma.com

Auditor

BDO USA, P.C.

Share holders

5

Employees

4

Evoke Pharma Inc Statistics

Valuation Measures

Market Capitalization2

6.79M

Enterprise Value

455.40K

Enterprise Value/EBITDA(ttm)

-0.08

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

0.81

Price to Book(mrq)

0.96

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

96.40%

Operating Margin(ttm)

-71.32%

Profit Margin(ttm)

-77.18%

Return on Equity(ttm)

-308.49%

Return on Invested Capital(ttm)

-45.59%

Return on Assets(ttm)

-53.66%

Income Statement

Revenue(ttm)

8.62M

Revenue Per Share(ttm)

5.80

Gross Profit(ttm)

8.32M

EBITDA(ttm)3

-5.90M

Net Income Available to Common(ttm)

-6.15M

Diluted EPS(ttm)

-10.99

Share Statistics

Beta (5Y Monthly)

0.16

52-Week Change

-72.66%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

1.49M

Dividend Yield

0.00%

Float4

1.40M

% Held by Insiders

6.10%

% Held by Institutions

0.00%

Balance Sheet

Total Cash(mrq)

11.34M

Total Cash Per Share(mrq)

7.63

Total Debt(mrq)

5.00M

Total Debt/Equity(mrq)

113.97%

Current Ratio(mrq)

1.44%

Quick Ratio(mrq)

1.39%

Book Value Per Share(mrq)

4.90

Cash Flow

Operating Cash Flow Per Share(ytd)

-3.01

Free Cash Flow(ytd)

-4.22M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement